Stock & Company Details
Gossamer Bio Inc $GOSS
Price:
N/A
N/A
6.1M
$60M
52 Week High:
N/A
10 Day Average Volume:
N/A
-12.62
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GOSS technical indicators
Latest Gossamer Bio Inc (GOSS) indicator readings as of 2026-10-09.
GOSS's 14-day RSI is 56.3, in neutral territory. At $9.31 it is trading 403.7% above its 200-day moving average of $1.85, and above its 50-day average of $4.67. Price sits below the lower Bollinger Band ($9.62 to $12.17). ADX reads 44.2, indicating a trending market.
Overview
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
Finance Bot
Ask your questions
Start by typing a question below.
